Total Payments
$10,613
2024 Payments
$2,082
Companies
37
Transactions
555
Medicare Patients
2,168
Medicare Billing
$244,684
Payment Breakdown by Category
Food & Beverage$10,574 (99.6%)
Education$39.07 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,574 | 553 | 99.6% |
| Education | $39.07 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,020 | 111 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,275 | 54 | $0 (2024) |
| Amgen Inc. | $1,138 | 54 | $0 (2024) |
| Janssen Biotech, Inc. | $929.61 | 53 | $0 (2024) |
| PFIZER INC. | $922.55 | 51 | $0 (2024) |
| UCB, Inc. | $806.12 | 63 | $0 (2024) |
| GlaxoSmithKline, LLC. | $447.75 | 25 | $0 (2024) |
| Lilly USA, LLC | $374.60 | 20 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $349.26 | 16 | $0 (2024) |
| Celgene Corporation | $250.26 | 12 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,082 | 101 | ABBVIE INC. ($403.36) |
| 2023 | $1,513 | 82 | Novartis Pharmaceuticals Corporation ($306.71) |
| 2022 | $1,796 | 95 | ABBVIE INC. ($334.73) |
| 2021 | $641.43 | 39 | AbbVie Inc. ($260.19) |
| 2020 | $434.79 | 25 | AbbVie Inc. ($116.26) |
| 2019 | $544.31 | 23 | AbbVie, Inc. ($272.50) |
| 2018 | $1,335 | 74 | Amgen Inc. ($257.36) |
| 2017 | $2,268 | 116 | Amgen Inc. ($376.03) |
All Payment Transactions
555 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: Bone Health | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Immunology | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $32.89 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Not Applicable | ||||||
| 11/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Immunology | ||||||
| 11/05/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Dermatology | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $1.26 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $8.62 | General |
| Category: Immunology | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 09/25/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Immunology | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $30.71 | General |
| Category: Dermatology | ||||||
| 09/18/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 406 | 1,918 | $167,869 | $58,676 |
| 2022 | 11 | 587 | 2,346 | $218,303 | $76,489 |
| 2021 | 10 | 562 | 1,870 | $183,910 | $66,711 |
| 2020 | 11 | 613 | 853 | $139,522 | $42,808 |
Total Patients
2,168
Total Services
6,987
Medicare Billing
$244,684
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 15 | 1,380 | $62,834 | $22,597 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 180 | 281 | $62,333 | $22,424 | 36.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 74 | 74 | $25,505 | $8,097 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 74 | $11,182 | $3,763 | 33.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 20 | 28 | $3,921 | $1,174 | 29.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 24 | $1,192 | $249.56 | 20.9% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 23 | 30 | $615.29 | $239.70 | 39.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 15 | 27 | $287.48 | $132.58 | 46.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 204 | 335 | $76,607 | $27,030 | 35.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 15 | 1,501 | $68,028 | $25,505 | 37.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 91 | 91 | $31,850 | $9,820 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 102 | 132 | $20,328 | $7,103 | 34.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 37 | 64 | $9,970 | $3,275 | 32.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $2,964 | $1,042 | 35.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 20 | 22 | $2,024 | $892.04 | 44.1% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 37 | 73 | $1,614 | $571.93 | 35.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 36 | 56 | $2,968 | $560.30 | 18.9% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 12 | 13 | $1,521 | $473.90 | 31.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 20 | 46 | $429.01 | $214.96 | 50.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 189 | 311 | $71,219 | $25,413 | 35.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 13 | 1,081 | $43,363 | $17,508 | 40.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 86 | 86 | $30,100 | $9,928 | 33.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 116 | 151 | $23,254 | $8,537 | 36.7% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 41 | 60 | $8,827 | $2,822 | 32.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 21 | 26 | $2,392 | $1,103 | 46.1% |
About Michael Brit
Michael Brit is a Rheumatology healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689692998.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Brit has received a total of $10,613 in payments from pharmaceutical and medical device companies, with $2,082 received in 2024. These payments were reported across 555 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($10,574).
As a Medicare-enrolled provider, Brit has provided services to 2,168 Medicare beneficiaries, totaling 6,987 services with total Medicare billing of $244,684. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Chattanooga, TN
- Active Since 07/17/2006
- Last Updated 03/27/2009
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1689692998
Products in Payments
- RINVOQ (Biological) $987.70
- XELJANZ (Drug) $851.95
- Cimzia (Drug) $761.37
- COSENTYX (Biological) $689.18
- Enbrel (Biological) $670.10
- TREMFYA (Drug) $542.29
- COSENTYX (Drug) $516.86
- Humira (Biological) $504.19
- BENLYSTA (Biological) $447.75
- ORENCIA (Biological) $349.26
- SIMPONI ARIA (Biological) $275.97
- SAPHNELO (Biological) $225.27
- Prolia (Biological) $222.76
- SKYRIZI (Biological) $213.57
- TALTZ (Drug) $206.45
- STELARA (Biological) $192.55
- HYRIMOZ (Biological) $180.17
- LUPKYNIS (Drug) $166.50
- Tymlos (Biological) $164.47
- KEVZARA (Drug) $144.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Chattanooga
Dr. Jonathan Mills, Md, MD
Rheumatology — Payments: $71,038
Rheumatology $71,038
Suzan House, Md, MD
Rheumatology — Payments: $63,468
Rheumatology $63,468
Richard Brackett, Md, MD
Rheumatology — Payments: $16,434
Rheumatology $16,434
Dr. Natalie Braggs, M.d, M.D
Rheumatology — Payments: $12,787
Rheumatology $12,787
Elizabeth Turner
Rheumatology — Payments: $12,473
Rheumatology $12,473
Dr. Melinda Garcia-Rosell, Md, MD
Rheumatology — Payments: $12,314
Rheumatology $12,314